Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that Francesco Marincola, MD, will join the company as Senior Vice President and Global Head of Cell Therapy Research, effective February 1. Dr. Marincola will lead Kite’s Research organization across hematological malignancies and solid tumors. “Franco’s proven track record in oncology and robust research experience that spans the NIH to industry will be critical to the targeting and acceleration of o

Click to view original post